Wendy Yan

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Wendy Yan

Wendy Yan

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Overview
RelSci Relationships

1388

Number of Boards

1

Birthday

1966

Age

55

Relationships
RelSci Relationships are individuals Wendy Yan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Relationship likelihood: Strong

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Relationship likelihood: Strong

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President of Clinical Development & Operations at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Biologics at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Discovery Biology at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Research Head of Chemistry at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Molecular Sciences at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Paths to Wendy Yan
Potential Connections via
Relationship Science
You
Wendy Yan
Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.
Education

The University has a proud heritage of delivering inspiring, vocationally-led education for 100 years at the heart of a county that is renowned for its legacy of pioneering and creative industrialists. The University has evolved into the modern forward thinking organisation it is today, but stays true to its core values by ensuring it remains a constant source of creative, technological and scientific knowledge and skills for the future.

Career History
Senior Vice President, Global Head of Regulatory Affairs
2014 - Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Senior Vice President of Regulatory Affairs
2014 - Current

BeiGene (Beijing) Co., Ltd., part of BeiGene Ltd., is a company headquartered in Beijing, China, that develops pharmaceuticals.

Director & Head-Regulatory Affairs
Prior

GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd., a subsidiary of Aurora Optoelectronics Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceuticals and technical toxicants. Aurora Optoelectronics Co., Ltd. acquired GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd. from GlaxoSmithKline Plc on 01 Feb 05 for $12.81 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wendy Yan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wendy Yan's profile does not indicate a business or promotional relationship of any kind between RelSci and Wendy Yan.